It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Pediatric Crohn’s disease (CD) is characterized by a severe disease course with frequent complications. We sought to apply machine learning-based models to predict risk of developing future complications in pediatric CD using ileal and colonic gene expression. Gene expression data was generated from 101 formalin-fixed, paraffin-embedded (FFPE) ileal and colonic biopsies obtained from treatment-naïve CD patients and controls. Clinical outcomes including development of strictures or fistulas and progression to surgery were analyzed using differential expression and modeled using machine learning. Differential expression analysis revealed downregulation of pathways related to inflammation and extra-cellular matrix production in patients with strictures. Machine learning-based models were able to incorporate colonic gene expression and clinical characteristics to predict outcomes with high accuracy. Models showed an area under the receiver operating characteristic curve (AUROC) of 0.84 for strictures, 0.83 for remission, and 0.75 for surgery. Genes with potential prognostic importance for strictures (REG1A, MMP3, and DUOX2) were not identified in single gene differential analysis but were found to have strong contributions to predictive models. Our findings in FFPE tissue support the importance of colonic gene expression and the potential for machine learning-based models in predicting outcomes for pediatric CD.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details

1 University of North Carolina at Chapel Hill, Center for Gastrointestinal Biology and Disease, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina at Chapel Hill, Department of Surgery, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
2 University of North Carolina at Chapel Hill, Center for Gastrointestinal Biology and Disease, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208); University of North Carolina at Chapel Hill, Departments of Genetics and Biology, Curriculum in Bioinformatics and Computational Biology, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
3 University of North Carolina at Chapel Hill, Joint Department of Biomedical Engineering, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000000122483208)
4 Cornell University, Department of Biomedical Sciences, College of Veterinary Medicine, Ithaca, USA (GRID:grid.5386.8) (ISNI:000000041936877X)
5 University of North Carolina at Chapel Hill, Center for Gastrointestinal Biology and Disease, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
6 University of North Carolina at Chapel Hill, Department of Pathology and Laboratory Medicine, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)
7 University of North Carolina at Chapel Hill, Department of Surgery, Chapel Hill, USA (GRID:grid.10698.36) (ISNI:0000 0001 2248 3208)